Back to Main

Faculty Detail    
Name MICHAEL ALLON
 
Campus Address PAUL 226
Phone 205-975-9676
E-mail mdallon@uab.edu
Other websites
     


Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Medicine  Med - Nephrology Professor
Center  General Clinical Research Center  Center for Outcomes & Effectiveness Res & Educ Professor
Center  Medicine  Comprehensive Diabetes Ctr Professor
Center  Medicine  Ctr Cardiovasc Bio Professor
Center  Medicine  Nephrology Res & Trng Ctr Professor

Biographical Sketch 
Michael Allon attended medical school at University of Michigan. He did his Residency in Internal Medicine and Fellowship in Nephrology at Emory University. He has been on the UAB faculty since 1990.

Society Memberships
Organization Name Position Held Org Link
American Society of Nephrology  Member   
International Society of Nephrology  Member   
National Kidney Foundation  Chair, Program Committee, 2008   

Research/Clinical Interest
Title
Vascular access in dialysis
Description
Dr. Allon has a clinical research interest in clinical dialysis, and in particular in vascular access for hemodialysis. He was a P.I. at UAB for the NIH-funded HEMO Study. This was a multi-center randomized clinical trial (1994-2002) evaluating the effect of dialysis dose and dialyzer flux on mortality and hospitalizations in hemodialysis patients. He is also a P.I. in the ongoing NIH-funded Dialysis access Consortium. This is a multicenter, randomized clinical trial evaluating pharmacologic intervention to reduce the failure of arteriovenous fistulas and grafts in hemodialysis patients. He also has a K-24 grant from NIDDK to study vascular access in hemodialysis. He has published over 60 peer-reviewed manuscripts on various aspects of vascular access, including editorial reviews. Finally, he has been an invited speaker at several national nephrology meetings on various topics related to vascular access.

Selected Publications 
Publication PUBMEDID
Allon M. Dialysis catheter-related bacteremia: Treatment and prophylaxis (Review). Am J Kidney Dis 44: 779-791, 2004  15492943 
Lee T, Barker J, Allon M. Associations with predialysis vascular access management. Am J Kidney Dis 43: 1008-1013, 2004  15168380 
Poole CV, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteremia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 19: 1237-1244, 2004  14993504 
Miller CD, Robbin ML, Barker J, Allon M. Comparison of arteriovenous grafts in the thigh and upper extremities in hemodialysis patients. J Am Soc Nephrol 14: 2942-2947, 2003  14569105 
Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ. Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO Study. J Am Soc Nephrol, 14: 1863-1870, 2003  12819247 
Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36: 1539-1544, 2003  12802753 
Eknoyan G, Beck GJ, Cheung AK, Daugirdas, JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux on mortality and morbidity in maintenance hemodialysis patients: Primary results of the HEMO Study. N Engl J Med 347: 2010-2019, 2002  12490682 
Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 63: 346-352, 2003  12472802 
Robbin ML, Chamberlain NE, Lockhart ME, Gallichio MH, Young CJ, Deierhoi MH, Allon M. Hemodialysis arteriovenous fistula maturity: US evaluation. Radiology, 225: 59-64, 2002  12354984 
Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney International 62: 1109-1124, 2002  12234281 
Krishnasami Z, Carlton D, Bimbo L, Taylor M.E., Balkovetz D.F., Barker J, Allon M. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney International 61: 1136-1142, 2002  11849468 
Allon M, Lockhart M, Lilly RZ Gallichio MH, Deierhoi MH, Young CJ, Robbin ML. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients Kidney International 60:2013-2020, 2001  11703621 
Lilly RZ, Carlton D, Barker J, Oser R, Hamrick K, Saddekni S, Westfall AO, Allon M. Clinical predictors of A-V graft patency following radiologic intervention in hemodialysis patients. Am J Kidney Dis 37: 945-9533, 2001  11325676 
Allon M, Ornt DB, Schwab S, Delmez JA, Greene T, Kusek JW, Martin AA, Minda S, Rasmussen C, and the HEMO Study Group. Factors associated with the prevalence of A-V fistulas in hemodialysis patients in the HEMO Study. Kidney Int 58: 2178-2185, 2000  11044239 
Robbin ML, Gallichio MH, Deierhoi MH, Young CJ, Weber TM, Allon M. US vascular mapping before hemodialysis access placement. Radiology 217: 83-88, 2000  11012427 
Allon M, Bailey R, Ballard R, Deierhoi MH, Hamrick K, Oser R, Rhynes VK, Robbin ML, Saddekni S, Zeigler ST. A multidisciplinary approach to hemodialysis access: prospective evaluation. Kidney Int 53: 473-479, 1998   
Miller PE, Tolwani A, Luscy CP, Deierhoi MH, Bailey R, Redden DT, Allon M. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int 56: 275-280, 1999   
Miller PE, Carlton D, Deierhoi MH, Redden DT, Allon M. Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 36: 68-74, 2000   

Keywords
Dialysis, vascular access, fistula, graft, dialysis catheter, infection.